Medication info

DapaRizin 5mg (Dapagliflozin Monohydrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Dapagliflozin Anhydrous Lactose Mixture›7.635mg / 1 tablet
Manufacturer / importer
Kooju Pharmaceutical Co., Ltd.
Appearance
Yellow, double convex, round film-coated tablet
Packaging
28 tablets/box [(7 tablets/PTP x 4, 14 tablets/PTP x 2)]
Approval status
Expired

MFDS item code 202005379 · Approved 2020.07.23

This product's status changed to Expired on 2025.07.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of antidiabetic drug therapy, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
Pediatric patients The efficacy and safety of dapagliflozin in pediatric patients under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Kooju Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar management disorder
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used as an adjunct therapy to assist in blood sugar control for patients with type 2 diabetes. It can be used alone or in combination with other medications, and it is important to accompany this treatment with diet and exercise. It is especially used for patients with cardiovascular disease or risk factors among those who do not have sufficient blood sugar control. It is advisable to review the clinical trial information from experts before use. This medication improves blood sugar management in type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of antidiabetic drug therapy, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

Pediatric patients The efficacy and safety of dapagliflozin in pediatric patients under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in patients who have had allergic reactions to the active ingredient or excipients. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with genetic disorders that prevent lactose breakdown should avoid this medication, as the included anhydrous lactose may cause problems. This medication is not administered to patients undergoing dialysis. This medication should be used cautiously in patients who have reduced fluid volume or kidney function issues. It may lower blood pressure and reduce blood volume, which can lead to symptomatic hypotension or kidney function deterioration. Patients with impaired kidney function, elderly patients, and those on diuretics are at greater risk, and their conditions should be closely monitored before and after administration. Caution is also necessary for patients with allergies to specific pigment components. During treatment, genital infections or urinary tract infections may occur, so immediate treatment is necessary if any infection symptoms arise. Symptoms of hypoglycemia may appear, especially when taken with insulin or sulfonylureas, so dosage adjustment may be necessary. Dehydration symptoms, dry mouth, and dizziness due to reduced fluid volume may occur, so adequate hydration and monitoring of symptoms are important. Severe metabolic instability known as diabetic ketoacidosis may rarely occur, so if symptoms such as abdominal pain, vomiting, or shortness of breath occur, immediate consultation with healthcare professionals is required. Regular kidney function tests are necessary as this medication may affect kidney function, and there may be an increase in creatinine levels. Rare but serious side effects, such as severe perineal necrosis (Fournier's gangrene), have been reported; if pain, swelling, or redness occurs around the genital area, inform a physician immediately. Women who are pregnant or nursing are advised against using this medication. This medication may increase the risk of hypoglycemia when used with other blood sugar-lowering agents; interactions with other medications being taken must be confirmed. There is no specific antidote for overdose; it is crucial to seek symptomatic treatment, and appropriate measures should be taken based on health status. Caution should be observed while driving or operating machinery during the course of this medication, especially in combination with insulin or sulfonylureas, due to the risk of hypoglycemia. Store this medication out of reach of children, and keep it in its original container to maintain quality.

Side effects

  • Vulvovaginitis
  • balanitis
  • genital infections
  • urinary tract infections
  • fungal infections
  • perineal necrosis
  • hypoglycemia
  • reduced fluid volume
  • thirst
  • diabetic ketoacidosis
Show 139 more
  • dizziness
  • constipation
  • dry mouth
  • back pain
  • dysuria
  • polyuria
  • nocturia
  • interstitial nephritis
  • vulvar pruritus
  • genital pruritus
  • increased hematocrit
  • decreased renal creatinine clearance
  • dyslipidemia
  • elevated serum creatinine
  • elevated blood urea nitrogen
  • weight loss
  • rash
  • angioedema
  • urosepsis
  • pyelonephritis
  • acute kidney injury
  • renal dysfunction
  • gastroesophageal reflux disease
  • epigastric pain
  • diverticulitis
  • bowel perforation
  • acute pancreatitis
  • chronic pancreatitis
  • hyperglycemia
  • paresthesia
  • cerebral infarction
  • nerve compression
  • sinusitis
  • pneumonia
  • pulmonary tuberculosis
  • myasthenia
  • pain
  • ligament sprain
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • cerebral hemorrhage
  • peripheral artery occlusion
  • angina
  • myocardial infarction
  • bile duct stones
  • cholangitis
  • alcoholic cirrhosis
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • anaphylactic reaction
  • chest pain
  • chest discomfort
  • fatigue
  • edema
  • foreign body sensation
  • facial edema
  • facial pain
  • warmth
  • flu-like symptoms
  • breast tumor
  • erectile dysfunction
  • benign prostatic hyperplasia
  • breast pain
  • genital rash
  • menorrhagia
  • genital edema
  • uterine bleeding
  • vaginal bleeding
  • hair loss
  • dermatitis
  • dry skin
  • allergic dermatitis
  • contact dermatitis
  • diabetic foot ulcer
  • hyperhidrosis eczema
  • nummular eczema
  • eczema
  • hyperkeratosis
  • onychopigmentation
  • skin lesions
  • urticaria
  • cold sweat
  • flank pain
  • fibromyalgia
  • limb discomfort
  • muscle cramps
  • musculoskeletal discomfort
  • osteopenia
  • contusion
  • orbital fracture
  • foot fracture
  • gastrointestinal foreign body
  • laceration
  • ligament rupture
  • limb injury
  • skin abrasion
  • tendon rupture
  • tibia fracture
  • dental damage
  • dry eye
  • eye pain
  • retinal disorders
  • vision loss
  • blepharitis
  • cataract
  • conjunctival edema
  • allergic conjunctivitis
  • conjunctivitis
  • diplopia
  • eyelid edema
  • glaucoma
  • visual impairment
  • vitreous floaters
  • oropharyngeal pain
  • allergic rhinitis
  • asthma
  • voice disorder
  • epistaxis
  • sleep apnea syndrome
  • wheezing
  • arteriosclerosis
  • flushing
  • peripheral coldness
  • varicose veins
  • vascular headache
  • orthostatic hypotension
  • atrial fibrillation
  • diastolic dysfunction
  • anxiety disorder
  • nocturia
  • auditory hallucinations
  • sleep disorder
  • insomnia
  • fatty liver
  • gallbladder polyp
  • dizziness
  • tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture, and it is advisable to keep it at room temperature between 1°C and 30°C. This storage helps maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Yellow, double convex, round film-coated tablet

Package unit

28 tablets/box [(7 tablets/PTP x 4, 14 tablets/PTP x 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.